Drug Study Finds Cypher, Taxus Stents Equally Safe
An 18-month trial comparing the use of the first two commercially available drug-eluting stents, Boston Scientific Corp.'s Taxus and Johnson & Johnson's Cypher, indicated that neither stent was more likely to...To view the full article, register now.
Already a subscriber? Click here to view full article